Furthermore, there was a negative correlation between decreased ARID1A expression and nuclear expression of p53 or β‐catenin, indicating that ARID1A may stimulate HCC growth via distinct mechanisms. The gene discussed is ARID1A; the disease is hepatocellular carcinoma.